You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

trabectedin

Showing 1 - 25 of 109
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Elderly Ovarian Cancer Treated With Trabectedin and PLD

Completed
  • Ovarian Cancer
  • Trabectedin and PLD
  • Córdoba, Spain
    Hospital Universitario Reina Sofía
May 22, 2023

Sarcoma, Sarcoma Metastatic Trial in Ann Arbor (Olaparib, Trabectedin)

Active, not recruiting
  • Sarcoma
  • Sarcoma Metastatic
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Dec 20, 2022

Leiomyosarcoma Trial in Santa Monica (Trabectedin)

Recruiting
  • Leiomyosarcoma
  • Trabectedin
  • Santa Monica, California
    Sant P Chawla
Oct 13, 2022

Soft Tissue Sarcoma Trial in Germany

Not yet recruiting
  • Soft Tissue Sarcoma
    • Bad Saarow, Germany
    • +8 more
    Sep 15, 2023

    Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed

    Completed
    • Ovarian Neoplasm
    • +4 more
      • (no location specified)
      Aug 22, 2022

      Uterine or Soft Tissue Leiomyosarcoma Trial in Villejuif (Doxorubicin, Trabectedin)

      Completed
      • Uterine or Soft Tissue Leiomyosarcoma
      • Villejuif, Val De Marne, France
        Gustave Roussy
      Dec 10, 2021

      Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Santa Monica (Trabectedin, Ipilimumab, Nivolumab)

      Recruiting
      • Advanced Soft Tissue Sarcoma
      • Metastatic Soft Tissue Sarcoma
      • Trabectedin
      • +2 more
      • Santa Monica, California
        Sarcoma Oncology Research Center
      May 4, 2022

      Soft Tissue Sarcoma Trial in Germany (Trabectedin, tTF-NGR)

      Recruiting
      • Soft Tissue Sarcoma
      • Trabectedin
      • tTF-NGR
      • Bad Saarow, Germany
      • +7 more
      Oct 24, 2022

      Soft Tissue Sarcoma Adult, Undifferentiated Pleomorphic Sarcoma, Epithelioid Sarcoma Trial in Bordeaux (Trabectedin)

      Recruiting
      • Soft Tissue Sarcoma Adult
      • +6 more
      • Trabectedin
      • Bordeaux, France
        Institut Bergonie
      Feb 1, 2022

      Ewing Sarcoma Trial in United States (drug, diagnostic test, other)

      Recruiting
      • Ewing Sarcoma
      • Trabectedin 1 MG [Yondelis]
      • +3 more
      • Los Angeles, California
      • +5 more
      Aug 15, 2022

      Liposarcoma, Myxoid, Sarcoma, Soft Tissue, Leiomyosarcoma Trial in France, Italy, Spain (Trabectedin, Radiotherapy)

      Recruiting
      • Liposarcoma, Myxoid
      • +4 more
      • Trabectedin
      • Radiotherapy
      • Bordeaux, France
      • +15 more
      Jun 6, 2022

      Cancers With DNA Repair-Deficiency Trial in Germany (Olaparib, Physician's choice, Trabectedin)

      Recruiting
      • Cancers With DNA Repair-Deficiency
      • Dresden, Germany
      • +8 more
      Jan 12, 2022

      Mesenchymal Chondrosarcoma Trial in Italy (Trabectedin)

      Active, not recruiting
      • Mesenchymal Chondrosarcoma
      • Trabectedin
      • Prato, Firenze, Italy
      • +5 more
      Oct 29, 2021

      Soft Tissue Sarcoma, Bone Tumors, Small Round-cell Sarcomas Trial in Barcelona, Madrid, Tenerife (Trabectedin)

      Recruiting
      • Soft Tissue Sarcoma
      • +2 more
      • Trabectedin
      • Barcelona, Cataluña, Spain
      • +6 more
      Nov 23, 2021

      Carcinosarcoma, Ovarian, Carcinosarcomas Uterine Trial in Rome (Trabectedin)

      Completed
      • Carcinosarcoma, Ovarian
      • Carcinosarcomas Uterine
      • Trabectedin
      • Rome, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Aug 24, 2021

      Solitary Fibrous Tumors Trial in Italy (Trabectedin, Adriamycin, Dacarbazine)

      Recruiting
      • Solitary Fibrous Tumors
      • Trabectedin
      • +2 more
      • Prato, Firenze, Italy
      • +5 more
      Oct 29, 2021

      Geriatric Assessmen of Elderly "Unsuited" Patients Receiving

      Completed
      • Advanced Soft-tissue Sarcoma
      • Metastatic Soft-tissue Sarcoma
      • No Intervention
      • Klagenfurt, Austria
      • +11 more
      Apr 1, 2022

      Sarcoma Trial in Santa Monica (Talimogene Laherparepvec 100000000 PFU/1 ML Injection Suspension [IMLYGIC], Nivolumab IV Soln 100

      Recruiting
      • Sarcoma
      • Talimogene Laherparepvec 100000000 PFU/1 ML Injection Suspension [IMLYGIC]
      • +2 more
      • Santa Monica, California
        Sarcoma Oncology Center
      Aug 17, 2021

      Relapsed Ovarian Cancer Trial in Roma (PLD and Trabectedin rechallenge)

      Recruiting
      • Relapsed Ovarian Cancer
      • PLD and Trabectedin rechallenge
      • Roma, Italy
        Fondazione Policlinico Gemelli IRCCS
      Aug 5, 2021

      Sarcoma, Soft Tissue Trial in Madrid (Olaratumab and Trabectedin)

      Active, not recruiting
      • Sarcoma, Soft Tissue
      • Olaratumab and Trabectedin
      • Madrid, Spain
        GEIS
      Apr 23, 2021

      Ovarian Tumors Trial in Rome (Trabectedin, Pegylated Liposomal Doxorubicin, Topotecan)

      Completed
      • Ovarian Neoplasms
      • Trabectedin
      • +5 more
      • Rome, Italy
        Domenica Lorusso
      Aug 24, 2021

      Advanced Soft Tissue Sarcoma Trial in Italy (Standard arm: Trabectedin in monotherapy, Experimental arm: Trabectedin + Olaparib)

      Recruiting
      • Advanced Soft Tissue Sarcoma
      • Standard arm: Trabectedin in monotherapy
      • Experimental arm: Trabectedin + Olaparib
      • Bologna, BO, Italy
      • +13 more
      Oct 29, 2021

      Soft-tissue Sarcomas Trial in Bordeaux (Phase 1: Trabectedin, Phase 2: Trabectedin, Phase 1: Cyclophosphamide)

      Active, not recruiting
      • Soft-tissue Sarcomas
      • Phase 1: Trabectedin
      • +3 more
      • Bordeaux, France
        Institut Bergonié
      May 4, 2021

      Leiomyosarcoma of Ovary, Soft Tissue Sarcoma Trial in Italy (Trabectedin, Gemcitabine, No Intervention: Observational Cohort)

      Active, not recruiting
      • Leiomyosarcoma of Ovary
      • Soft Tissue Sarcoma
      • Trabectedin
      • +2 more
      • Bologna, BO, Italy
      • +12 more
      Oct 29, 2021

      Ovarian Carcinoma, Soft Tissue Sarcoma Trial in Bordeaux, Lyon (Combination of trabectedin with durvalumab)

      Active, not recruiting
      • Ovarian Carcinoma
      • Soft Tissue Sarcoma
      • Combination of trabectedin with durvalumab
      • Bordeaux, France
      • +1 more
      May 4, 2021